TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
RDNT

RadNet Inc

Healthcare · Diagnostics & Research

70.80$ -0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

RadNet Inc (RDNT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 88 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RDNT
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
3.3 37 31 19 25 66 24 23 41 29 27 18 38 22 41 91 39 63 28 31 42 49 0.9 65 27 54 33 68 31 89 17 116 57 43 41 120 53 84 92 88 317
17 17 17 17 17 16 18 18 17 19 36 37 38 37 39 39 39 39 41 43 44 44 44 46 47 48 47 48 48 46 32 34 35 97 35 37 40 41 45 46 171
1.2 0.9 3.3 1.0 1.5 0.9 3.7 1.1 1.7 1.1 4.5 1.0 1.4 1.8 6.6 1.5 2.1 2.3 8.2 8.9 4.4 3.6 11 4.7 3.3 4.7 12 4.9 4.3 5.4 12 4.7 4.7 8.5 28 8.7 9.0 8.3 31 11 59
12 -33 14 13 12 27 -1.1 4.4 15 -2.0 1.5 -1.0 0.3 3.5 -6.0 3.4 11 8.8 -3.3 3.4 5.7 8.5 -10 -1.7 -7.3 13 18 6.3 – – – – – – – – – – – – –
-28 3.8 -1.0 -14 -9.5 45 9.3 -4.7 3.5 10 -10 -29 -6.6 -32 9.2 5.5 -18 1.1 -22 -29 -26 -16 -41 8.4 -16 -9.5 -19 -5.7 -27 5.9 -45 45 -16 -40 -14 16 -28 2.8 25 4.4 3.6
12 7.2 34 19 23 13 30 29 21 65 36 42 18 21 56 13 13 6.7 30 31 35 49 37 36 26 151 56 30 41 40 57 47 41 43 49 53 60 315 70 70 515
-12 -6.5 -34 -12 -20 -12 -30 -31 -20 -65 -35 -42 -17 -5.5 -55 -13 -21 -38 -87 -32 -40 -62 -62 -34 -27 -124 -66 -40 -47 -44 -61 -77 -46 -49 -57 -97 -76 -114 -371 -64 -624
0.3 0.7 0.5 0.2 0.4 0.5 0.8 0.2 0.0 0.5 – – – – – – 0.5 1.6 2.3 5.4 8.3 6.3 – – – – – – – – – – – – – – – – – – –
-0.3 -1.5 -0.5 4.7 -5.3 -6.4 0.0 -0.9 -0.2 -0.5 0.1 0.1 -1.8 -1.2 – – -0.6 -1.4 – 0.0 – -2.0 – – – -0.6 0.1 243 -0.4 – – – – – – – – – – – –
9.8 -5.1 -8.8 -7.7 -12 -9.8 -10 -9.9 -9.3 17 2.3 46 -14 -13 68 -92 -12 -12 -12 111 -2.9 -3.3 -3.3 -3.3 -3.3 104 -3.9 -4.6 – – – – -7.7 -5.8 -6.7 92 -7.0 -7.0 -15 241 212
9.1 -10 -9.3 -2.9 -9.8 -10 -11 -10 -9.4 19 8.3 44 -14 -14 68 -88 -14 -12 -12 111 8.7 -3.8 -3.3 -3.3 -3.3 104 -3.8 238 -3.2 -41 228 176 -4.3 -2.1 -7.5 92 -5.3 -7.4 -31 246 202
-0.1 20 -12 4.4 -4.2 43 -16 -19 11 -17 0.0 20 7.2 2.5 54 -9.7 4.2 12 -71 110 10 -17 -64 28 -4.2 33 -37 266 -19 4.7 184 215 7.2 -8.9 -23 116 -28 -38 -312 271 -107
-8.5 30 -2.6 0.2 2.3 52 -5.5 -6.8 20 -36 -9.0 -24 20 43 -15 78 26 56 -2.3 -0.6 6.9 -0.2 -36 29 1.1 -97 -23 38 -9.9 49 -40 69 16 -0.4 -7.4 67 -7.6 -231 22 158 -58

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?